Are tumor size changes predictive of survival for checkpoint blockade based immunotherapy in metastatic melanoma?
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Are tumor size changes predictive of survival for checkpoint blockade based immunotherapy in metastatic melanoma? ; volume:7 ; number:1 ; day:8 ; month:2 ; year:2019 ; pages:1-10 ; date:12.2019
Journal for ImmunoTherapy of Cancer ; 7, Heft 1 (8.2.2019), 1-10, 12.2019
- Urheber
-
Wang, Meihua
Chen, Cong
Jemielita, Thomas
Anderson, James
Li, Xiaoyun (Nicole)
Hu, Chen
Kang, S. Peter
Ibrahim, Nageatte
Ebbinghaus, Scot
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40425-019-0513-4
- URN
-
urn:nbn:de:101:1-2019031017204782509199
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wang, Meihua
- Chen, Cong
- Jemielita, Thomas
- Anderson, James
- Li, Xiaoyun (Nicole)
- Hu, Chen
- Kang, S. Peter
- Ibrahim, Nageatte
- Ebbinghaus, Scot
- SpringerLink (Online service)
Ähnliche Objekte (12)
Is there a role for immune checkpoint blockade in metastatic uveal melanoma?
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity
Paraneoplastic acral vascular syndrome in a patient with metastatic melanoma under immune checkpoint blockade
Metastatic melanoma to small bowel: metastasectomy is supported in the era of immunotherapy and checkpoint inhibitors
The Role of Immune Checkpoint Blockade in Uveal Melanoma
Mixed Response to Immunotherapy in Patients with Metastatic Melanoma
Proteomic test for anti-PD-1 checkpoint blockade treatment of metastatic melanoma with and without BRAF mutations
A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
Molecular patterns of resistance to immune checkpoint blockade in melanoma
Predictors of responses to immune checkpoint blockade in advanced melanoma
Is there a role for immune checkpoint blockade in metastatic uveal melanoma?
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity
Paraneoplastic acral vascular syndrome in a patient with metastatic melanoma under immune checkpoint blockade
Metastatic melanoma to small bowel: metastasectomy is supported in the era of immunotherapy and checkpoint inhibitors
The Role of Immune Checkpoint Blockade in Uveal Melanoma
Mixed Response to Immunotherapy in Patients with Metastatic Melanoma
Proteomic test for anti-PD-1 checkpoint blockade treatment of metastatic melanoma with and without BRAF mutations
A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
Molecular patterns of resistance to immune checkpoint blockade in melanoma
Predictors of responses to immune checkpoint blockade in advanced melanoma
Is there a role for immune checkpoint blockade in metastatic uveal melanoma?
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity
Paraneoplastic acral vascular syndrome in a patient with metastatic melanoma under immune checkpoint blockade
Metastatic melanoma to small bowel: metastasectomy is supported in the era of immunotherapy and checkpoint inhibitors
The Role of Immune Checkpoint Blockade in Uveal Melanoma
Mixed Response to Immunotherapy in Patients with Metastatic Melanoma
Proteomic test for anti-PD-1 checkpoint blockade treatment of metastatic melanoma with and without BRAF mutations
A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
Molecular patterns of resistance to immune checkpoint blockade in melanoma